Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1974 8
1975 10
1976 14
1977 26
1978 42
1979 54
1980 50
1981 61
1982 59
1983 82
1984 109
1985 102
1986 109
1987 101
1988 101
1989 140
1990 163
1991 200
1992 203
1993 257
1994 279
1995 311
1996 332
1997 423
1998 350
1999 370
2000 365
2001 387
2002 384
2003 359
2004 346
2005 393
2006 372
2007 369
2008 339
2009 331
2010 307
2011 294
2012 249
2013 292
2014 283
2015 263
2016 248
2017 211
2018 237
2019 204
2020 231
2021 259
2022 216
2023 188
2024 52

Text availability

Article attribute

Article type

Publication date

Search Results

10,431 results

Results by year

Filters applied: . Clear all
Page 1
Efficacy and safety of intravenous levosimendan compared with dobutamine in severe low-output heart failure (the LIDO study): a randomised double-blind trial.
Follath F, Cleland JG, Just H, Papp JG, Scholz H, Peuhkurinen K, Harjola VP, Mitrovic V, Abdalla M, Sandell EP, Lehtonen L; Steering Committee and Investigators of the Levosimendan Infusion versus Dobutamine (LIDO) Study. Follath F, et al. Lancet. 2002 Jul 20;360(9328):196-202. doi: 10.1016/s0140-6736(02)09455-2. Lancet. 2002. PMID: 12133653 Clinical Trial.
FINDINGS: 103 patients were assigned levosimendan and 100 dobutamine. The primary haemodynamic endpoint was achieved in 29 (28%) levosimendan-group patients and 15 (15%) in the dobutamine group (hazard ratio 1.9 [95% CI 1.1-3.3]; p=0.022). ...This benefit was accomp …
FINDINGS: 103 patients were assigned levosimendan and 100 dobutamine. The primary haemodynamic endpoint was achieved in 29 (28%) levo …
Dobutamine: ten years later.
Majerus TC, Dasta JF, Bauman JL, Danziger LH, Ruffolo RR Jr. Majerus TC, et al. Pharmacotherapy. 1989;9(4):245-59. doi: 10.1002/j.1875-9114.1989.tb04133.x. Pharmacotherapy. 1989. PMID: 2671957 Review.
Dobutamine is a commonly used positive inotrope for the short-term management of heart failure. ...With this in mind, monotherapy or combination therapy with inodilators such as dobutamine, or inopressors like dopamine will follow logically....
Dobutamine is a commonly used positive inotrope for the short-term management of heart failure. ...With this in mind, monotherapy or …
The pharmacology of dobutamine.
Ruffolo RR Jr. Ruffolo RR Jr. Am J Med Sci. 1987 Oct;294(4):244-8. doi: 10.1097/00000441-198710000-00005. Am J Med Sci. 1987. PMID: 3310640 Review.
Dobutamine is a sympathomimetic amine that was designed as an inotropic agent for use in congestive heart failure. ...This hemodynamic profile of dobutamine makes the drug of value in the management of low output cardiac failure. ...
Dobutamine is a sympathomimetic amine that was designed as an inotropic agent for use in congestive heart failure. ...This hemodynami …
Inotropic agents.
Vincent JL, Preiser JC. Vincent JL, et al. New Horiz. 1993 Feb;1(1):137-44. New Horiz. 1993. PMID: 7922387 Review.
Dopamine remains the drug of choice in the resuscitation of septic shock but norepinephrine can also have a place in the treatment of profound cardiovascular collapse or severe right ventricular failure. Dobutamine has become the inotropic agent of choice to increase DO2 t …
Dopamine remains the drug of choice in the resuscitation of septic shock but norepinephrine can also have a place in the treatment of profou …
A Literature Review of the Pharmacokinetics and Pharmacodynamics of Dobutamine in Neonates.
Mahoney L, Shah G, Crook D, Rojas-Anaya H, Rabe H. Mahoney L, et al. Pediatr Cardiol. 2016 Jan;37(1):14-23. doi: 10.1007/s00246-015-1263-9. Epub 2015 Sep 7. Pediatr Cardiol. 2016. PMID: 26346024 Review.
Since its discovery in 1975 dobutamine has been used off-label for treating hemodynamic insufficiency in newborns and children. ...While the pharmacodynamic effects of dobutamine appear to reflect the pharmacological profile of the drug, the pharmacokinetic data are …
Since its discovery in 1975 dobutamine has been used off-label for treating hemodynamic insufficiency in newborns and children. ...Wh …
[Pharmacology of dobutamine].
Martin C, Martin A, Saux P, Chevalier A. Martin C, et al. Ann Anesthesiol Fr. 1981;22(6):623-30. Ann Anesthesiol Fr. 1981. PMID: 6124192 Review. French. No abstract available.
The effect of dobutamine in sepsis: a propensity score matched analysis.
Zhu Y, Yin H, Zhang R, Ye X, Wei J. Zhu Y, et al. BMC Infect Dis. 2021 Nov 11;21(1):1151. doi: 10.1186/s12879-021-06852-8. BMC Infect Dis. 2021. PMID: 34758739 Free PMC article.
BACKGROUND: The use of dobutamine in patients with sepsis is questionable currently. As the benefit of dobutamine in septic patients is unclear, we aimed to evaluate whether the use of dobutamine was associated with decreased hospital mortality in sepsis pati …
BACKGROUND: The use of dobutamine in patients with sepsis is questionable currently. As the benefit of dobutamine in septic pa …
Unexpected Creatinine Values.
Oudart JB, Braham ID, Maquart FX. Oudart JB, et al. Clin Chem. 2016 Dec;62(12):1675-1676. doi: 10.1373/clinchem.2016.263038. Clin Chem. 2016. PMID: 27899460 No abstract available.
Dobutamine.
Noerr B. Noerr B. Neonatal Netw. 1994 Oct;13(7):61-3. Neonatal Netw. 1994. PMID: 7862069 No abstract available.
Venoarterial extracorporeal membrane oxygenation flow or dobutamine to improve microcirculation during ECMO for refractory cardiogenic shock.
Chommeloux J, Montero S, Franchineau G, Lebreton G, Bréchot N, Barhoum P, Lefèvre L, de Chambrun MP, Hékimian G, Luyt CE, Combes A, Schmidt M. Chommeloux J, et al. J Crit Care. 2022 Oct;71:154090. doi: 10.1016/j.jcrc.2022.154090. Epub 2022 Jun 11. J Crit Care. 2022. PMID: 35700546
We investigated the respective impact of increasing VA ECMO flow or dobutamine dose on microcirculation in stabilized VA ECMO-treated patients with rCS. ...Baseline was defined as the lowest VA ECMO flow and dobutamine 5 mug/kg/min (DOBU(5)) to maintain mean arteria …
We investigated the respective impact of increasing VA ECMO flow or dobutamine dose on microcirculation in stabilized VA ECMO-treated …
10,431 results
You have reached the last available page of results. Please see the User Guide for more information.